Introduction Neonatal jaundice is the most common physiologic variant encountered in the newborn. More than 60% of healthy term neonates, and even a greater percentage of breastfed infants, display some degree of visible jaundice during the first week of life.…
Introduction Neonatal jaundice is a common phenomenon, noted in more than 80% of otherwise healthy, term newborns. , In the majority of cases, the jaundice is transient, usually resolving by the end of the first postnatal week, and serum total…
Bilirubin is one of three biologically active end-products of heme catabolism. Its clinical significance in the neonate relates to its propensity for deposition in the skin and mucous membranes, producing easily identifiable jaundice (French jaune , yellow) or icterus (Greek…